SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (4753)1/18/1998 10:53:00 PM
From: Bradpalm1  Read Replies (3) of 23519
 
Let me propose a hypothetical question. Once Viagra is approved and released, why would a PCP bother with the time-consuming task of prescribing and titrating Muse dosages in the office? If some of these patients eventually fail Viagra, I believe that they would be far more likely to refer them to a urologist for further evaluation and management rather than turning to a more invasive treatment option. Therefore, could the money that Vivus spent spending on the marketing material and video tape in those yellow boxes sent to PCPs been better spent? Any thoughts?

Bradpalm1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News